Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
46.14
Dollar change
-0.78
Percentage change
-1.66
%
Index- P/E- EPS (ttm)-2.17 Insider Own1.26% Shs Outstand55.87M Perf Week-3.13%
Market Cap2.54B Forward P/E14.64 EPS next Y3.15 Insider Trans0.00% Shs Float55.17M Perf Month-0.67%
Income-119.19M PEG- EPS next Q0.91 Inst Own109.00% Short Float7.66% Perf Quarter8.59%
Sales2.00B P/S1.27 EPS this Y15.83% Inst Trans0.31% Short Ratio6.27 Perf Half Y2.90%
Book/sh59.61 P/B0.77 EPS next Y13.37% ROA-2.44% Short Interest4.22M Perf Year-11.47%
Cash/sh0.64 P/C71.58 EPS next 5Y21.10% ROE-3.59% 52W Range38.27 - 65.03 Perf YTD-17.64%
Dividend Est.- P/FCF- EPS past 5Y- ROI-2.53% 52W High-29.05% Beta1.77
Dividend TTM- Quick Ratio1.12 Sales past 5Y1.85% Gross Margin49.11% 52W Low20.56% ATR (14)1.32
Dividend Ex-Date- Current Ratio2.27 EPS Y/Y TTM-30.44% Oper. Margin-1.59% RSI (14)48.02 Volatility2.08% 2.69%
Employees6550 Debt/Eq0.42 Sales Y/Y TTM20.52% Profit Margin-5.95% Recom1.27 Target Price66.30
Option/ShortYes / Yes LT Debt/Eq0.41 EPS Q/Q-67.94% Payout- Rel Volume0.74 Prev Close46.92
Sales Surprise0.15% EPS Surprise18.53% Sales Q/Q21.00% EarningsNov 06 BMO Avg Volume673.89K Price46.14
SMA20-2.29% SMA504.63% SMA200-4.55% Trades Volume496,454 Change-1.66%
Date Action Analyst Rating Change Price Target Change
Oct-03-24Initiated JMP Securities Mkt Outperform $62
Jun-13-24Initiated JP Morgan Neutral $53
Feb-13-24Initiated Stephens Overweight $72
Jan-22-24Initiated UBS Buy $75
Jan-03-24Initiated William Blair Outperform
Dec-15-23Reiterated Needham Buy $62 → $70
Oct-20-23Initiated ROTH MKM Buy $75
Jun-26-23Initiated Needham Buy $70
May-12-23Upgrade Wells Fargo Equal Weight → Overweight $55 → $67
Oct-12-22Initiated Jefferies Buy $60
Nov-18-24 04:10PM
Nov-08-24 12:00PM
09:55AM
Nov-07-24 02:10AM
12:58AM
07:15AM Loading…
Nov-06-24 07:15AM
06:17AM
06:00AM
Oct-31-24 12:02PM
04:32AM
Oct-10-24 07:00AM
Oct-03-24 03:39PM
Sep-09-24 03:50PM
Sep-05-24 08:00AM
05:29AM
11:54AM Loading…
Aug-20-24 11:54AM
08:00AM
05:52AM
Aug-19-24 08:00AM
Aug-12-24 04:10PM
04:12AM
Aug-08-24 05:11AM
Aug-07-24 07:15AM
06:13AM
06:00AM
Jul-31-24 10:01AM
01:49AM
Jul-25-24 06:00AM
Jul-16-24 07:00AM
Jul-15-24 10:24AM
04:12AM Loading…
04:12AM
Jul-12-24 08:00AM
02:14AM
May-15-24 02:01PM
May-10-24 06:00AM
May-07-24 09:35AM
May-06-24 09:35AM
May-03-24 11:22AM
03:04AM
May-02-24 11:48AM
10:56AM
07:55AM
07:10AM
06:11AM
06:00AM
Apr-25-24 11:34AM
Apr-17-24 07:00AM
Apr-16-24 08:00AM
Mar-28-24 07:00AM
Feb-23-24 10:20AM
Feb-22-24 11:06PM
06:31AM
06:23AM
06:00AM
Feb-12-24 11:30AM
Feb-07-24 04:15PM
Jan-29-24 08:00AM
Jan-26-24 06:00AM
Jan-25-24 08:30AM
Jan-04-24 10:53AM
Jan-03-24 06:00AM
Dec-28-23 05:00AM
Dec-05-23 06:00AM
Nov-29-23 09:55AM
Nov-16-23 04:15PM
Nov-13-23 09:55AM
Nov-08-23 08:42PM
08:43AM
01:16AM
Nov-07-23 09:51PM
07:15AM
06:50AM
06:12AM
06:00AM
Oct-31-23 10:01AM
Oct-30-23 08:00AM
Oct-25-23 12:10PM
Oct-20-23 06:00AM
Oct-19-23 06:58AM
06:51AM
Oct-16-23 07:00AM
Sep-29-23 11:34AM
Sep-25-23 06:35AM
06:00AM
05:00AM
Sep-18-23 08:30AM
Sep-07-23 08:40AM
Aug-08-23 08:24AM
Aug-03-23 10:43AM
07:25AM
06:21AM
06:00AM
Jul-21-23 04:34AM
Jul-11-23 04:45PM
Jul-10-23 07:28AM
Jul-06-23 08:30AM
Jul-03-23 04:27AM
Jun-28-23 04:30PM
Jun-14-23 07:21AM
07:06AM
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.